Hillsdale Investment Management Inc. Increases Stock Holdings in Tenet Healthcare Corporation $THC

Hillsdale Investment Management Inc. lifted its position in Tenet Healthcare Corporation (NYSE:THC) by 20.6% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 27,490 shares of the company’s stock after buying an additional 4,690 shares during the quarter. Hillsdale Investment Management Inc.’s holdings in Tenet Healthcare were worth $5,463,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also bought and sold shares of the stock. Boston Partners raised its stake in Tenet Healthcare by 38.8% in the third quarter. Boston Partners now owns 3,147,555 shares of the company’s stock valued at $638,958,000 after purchasing an additional 880,413 shares in the last quarter. Ameriprise Financial Inc. raised its stake in Tenet Healthcare by 8.0% in the second quarter. Ameriprise Financial Inc. now owns 2,119,423 shares of the company’s stock valued at $373,020,000 after purchasing an additional 157,109 shares in the last quarter. AQR Capital Management LLC raised its stake in Tenet Healthcare by 62.3% in the third quarter. AQR Capital Management LLC now owns 1,876,423 shares of the company’s stock valued at $380,989,000 after purchasing an additional 720,160 shares in the last quarter. Eminence Capital LP purchased a new stake in Tenet Healthcare in the third quarter valued at approximately $225,263,000. Finally, Bank of America Corp DE raised its stake in Tenet Healthcare by 9.6% in the third quarter. Bank of America Corp DE now owns 1,078,585 shares of the company’s stock valued at $218,996,000 after purchasing an additional 94,903 shares in the last quarter. 95.44% of the stock is owned by hedge funds and other institutional investors.

Tenet Healthcare Stock Up 0.9%

Shares of Tenet Healthcare stock opened at $174.83 on Friday. The company has a debt-to-equity ratio of 1.96, a quick ratio of 1.30 and a current ratio of 1.36. Tenet Healthcare Corporation has a 52-week low of $146.60 and a 52-week high of $247.21. The stock has a market capitalization of $15.06 billion, a price-to-earnings ratio of 9.09, a P/E/G ratio of 1.15 and a beta of 1.30. The company’s 50 day moving average price is $189.94 and its 200-day moving average price is $201.87.

Tenet Healthcare (NYSE:THC) last issued its earnings results on Thursday, April 30th. The company reported $4.82 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.21 by $0.61. Tenet Healthcare had a net margin of 7.94% and a return on equity of 25.55%. The firm had revenue of $5.37 billion for the quarter, compared to analysts’ expectations of $5.39 billion. During the same quarter last year, the business earned $4.36 earnings per share. The business’s revenue was up 2.6% on a year-over-year basis. Tenet Healthcare has set its FY 2026 guidance at 16.380-18.68 EPS. Equities research analysts forecast that Tenet Healthcare Corporation will post 17.67 EPS for the current year.

Insiders Place Their Bets

In related news, Director J Robert Kerrey sold 5,638 shares of Tenet Healthcare stock in a transaction on Thursday, May 28th. The shares were sold at an average price of $174.52, for a total value of $983,943.76. Following the sale, the director owned 16,804 shares in the company, valued at $2,932,634.08. The trade was a 25.12% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, EVP Paola M. Arbour sold 6,500 shares of Tenet Healthcare stock in a transaction on Wednesday, March 11th. The shares were sold at an average price of $238.43, for a total transaction of $1,549,795.00. Following the completion of the sale, the executive vice president owned 29,291 shares in the company, valued at approximately $6,983,853.13. This trade represents a 18.16% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 55,155 shares of company stock valued at $12,459,105 over the last quarter. 0.97% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

A number of equities research analysts recently weighed in on the stock. Cantor Fitzgerald reaffirmed an “overweight” rating on shares of Tenet Healthcare in a research note on Wednesday, March 4th. Robert W. Baird reduced their price target on shares of Tenet Healthcare from $245.00 to $210.00 and set a “neutral” rating on the stock in a research report on Tuesday, May 5th. Morgan Stanley set a $254.00 price target on shares of Tenet Healthcare in a research report on Friday, May 1st. Weiss Ratings reiterated a “buy (b-)” rating on shares of Tenet Healthcare in a research report on Friday, March 27th. Finally, TD Cowen reiterated a “buy” rating on shares of Tenet Healthcare in a research report on Thursday, February 12th. Nineteen equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $244.16.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.